Publisher： Bentham Science Publishers
E-ISSN： 1873-5592|5|6|565-571
ISSN： 1389-4501
Source： Current Drug Targets, Vol.5, Iss.6, 2004-08, pp. : 565-571
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
By Bak Ann Mosegaard Egefjord Lærke Gejl Michael Steffensen Charlotte Stecher Chalotte Willemann Smidt Kamille Brock Birgitte Rungby Jørgen
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. :
Access to resources
Recommend
GLP-1 agonists: a new approach for type 2 diabetes
Inpharma, Vol. 1, Iss. 1407, 2003-01 ,pp. :
New and emerging treatments for Alzheimer's disease
Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. :